Cargando…

Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro

Adverse outcome pathways (AOPs) are organized sequences of key events (KEs) that are triggered by a xenobiotic-induced molecular initiating event (MIE) and summit in an adverse outcome (AO) relevant to human or ecological health. The AOP framework causally connects toxicological mechanistic informat...

Descripción completa

Detalles Bibliográficos
Autores principales: Klose, Jördis, Li, Lu, Pahl, Melanie, Bendt, Farina, Hübenthal, Ulrike, Jüngst, Christian, Petzsch, Patrick, Schauss, Astrid, Köhrer, Karl, Leung, Ping Chung, Wang, Chi Chiu, Koch, Katharina, Tigges, Julia, Fan, Xiaohui, Fritsche, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042984/
https://www.ncbi.nlm.nih.gov/pubmed/35701726
http://dx.doi.org/10.1007/s10565-022-09730-4
_version_ 1784913051489665024
author Klose, Jördis
Li, Lu
Pahl, Melanie
Bendt, Farina
Hübenthal, Ulrike
Jüngst, Christian
Petzsch, Patrick
Schauss, Astrid
Köhrer, Karl
Leung, Ping Chung
Wang, Chi Chiu
Koch, Katharina
Tigges, Julia
Fan, Xiaohui
Fritsche, Ellen
author_facet Klose, Jördis
Li, Lu
Pahl, Melanie
Bendt, Farina
Hübenthal, Ulrike
Jüngst, Christian
Petzsch, Patrick
Schauss, Astrid
Köhrer, Karl
Leung, Ping Chung
Wang, Chi Chiu
Koch, Katharina
Tigges, Julia
Fan, Xiaohui
Fritsche, Ellen
author_sort Klose, Jördis
collection PubMed
description Adverse outcome pathways (AOPs) are organized sequences of key events (KEs) that are triggered by a xenobiotic-induced molecular initiating event (MIE) and summit in an adverse outcome (AO) relevant to human or ecological health. The AOP framework causally connects toxicological mechanistic information with apical endpoints for application in regulatory sciences. AOPs are very useful to link endophenotypic, cellular endpoints in vitro to adverse health effects in vivo. In the field of in vitro developmental neurotoxicity (DNT), such cellular endpoints can be assessed using the human “Neurosphere Assay,” which depicts different endophenotypes for a broad variety of neurodevelopmental KEs. Combining this model with large-scale transcriptomics, we evaluated DNT hazards of two selected Chinese herbal medicines (CHMs) Lei Gong Teng (LGT) and Tian Ma (TM), and provided further insight into their modes-of-action (MoA). LGT disrupted hNPC migration eliciting an exceptional migration endophenotype. Time-lapse microscopy and intervention studies indicated that LGT disturbs laminin-dependent cell adhesion. TM impaired oligodendrocyte differentiation in human but not rat NPCs and activated a gene expression network related to oxidative stress. The LGT results supported a previously published AOP on radial glia cell adhesion due to interference with integrin-laminin binding, while the results of TM exposure were incorporated into a novel putative, stressor-based AOP. This study demonstrates that the combination of phenotypic and transcriptomic analyses is a powerful tool to elucidate compounds’ MoA and incorporate the results into novel or existing AOPs for a better perception of the DNT hazard in a regulatory context. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10565-022-09730-4.
format Online
Article
Text
id pubmed-10042984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-100429842023-03-29 Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro Klose, Jördis Li, Lu Pahl, Melanie Bendt, Farina Hübenthal, Ulrike Jüngst, Christian Petzsch, Patrick Schauss, Astrid Köhrer, Karl Leung, Ping Chung Wang, Chi Chiu Koch, Katharina Tigges, Julia Fan, Xiaohui Fritsche, Ellen Cell Biol Toxicol Original Article Adverse outcome pathways (AOPs) are organized sequences of key events (KEs) that are triggered by a xenobiotic-induced molecular initiating event (MIE) and summit in an adverse outcome (AO) relevant to human or ecological health. The AOP framework causally connects toxicological mechanistic information with apical endpoints for application in regulatory sciences. AOPs are very useful to link endophenotypic, cellular endpoints in vitro to adverse health effects in vivo. In the field of in vitro developmental neurotoxicity (DNT), such cellular endpoints can be assessed using the human “Neurosphere Assay,” which depicts different endophenotypes for a broad variety of neurodevelopmental KEs. Combining this model with large-scale transcriptomics, we evaluated DNT hazards of two selected Chinese herbal medicines (CHMs) Lei Gong Teng (LGT) and Tian Ma (TM), and provided further insight into their modes-of-action (MoA). LGT disrupted hNPC migration eliciting an exceptional migration endophenotype. Time-lapse microscopy and intervention studies indicated that LGT disturbs laminin-dependent cell adhesion. TM impaired oligodendrocyte differentiation in human but not rat NPCs and activated a gene expression network related to oxidative stress. The LGT results supported a previously published AOP on radial glia cell adhesion due to interference with integrin-laminin binding, while the results of TM exposure were incorporated into a novel putative, stressor-based AOP. This study demonstrates that the combination of phenotypic and transcriptomic analyses is a powerful tool to elucidate compounds’ MoA and incorporate the results into novel or existing AOPs for a better perception of the DNT hazard in a regulatory context. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10565-022-09730-4. Springer Netherlands 2022-06-15 2023 /pmc/articles/PMC10042984/ /pubmed/35701726 http://dx.doi.org/10.1007/s10565-022-09730-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Klose, Jördis
Li, Lu
Pahl, Melanie
Bendt, Farina
Hübenthal, Ulrike
Jüngst, Christian
Petzsch, Patrick
Schauss, Astrid
Köhrer, Karl
Leung, Ping Chung
Wang, Chi Chiu
Koch, Katharina
Tigges, Julia
Fan, Xiaohui
Fritsche, Ellen
Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
title Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
title_full Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
title_fullStr Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
title_full_unstemmed Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
title_short Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
title_sort application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of chinese herbal medicines by using human neural progenitor cells in vitro
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042984/
https://www.ncbi.nlm.nih.gov/pubmed/35701726
http://dx.doi.org/10.1007/s10565-022-09730-4
work_keys_str_mv AT klosejordis applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT lilu applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT pahlmelanie applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT bendtfarina applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT hubenthalulrike applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT jungstchristian applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT petzschpatrick applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT schaussastrid applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT kohrerkarl applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT leungpingchung applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT wangchichiu applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT kochkatharina applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT tiggesjulia applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT fanxiaohui applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro
AT fritscheellen applicationoftheadverseoutcomepathwayconceptforinvestigatingdevelopmentalneurotoxicitypotentialofchineseherbalmedicinesbyusinghumanneuralprogenitorcellsinvitro